Global influenza vaccine market was valued at US$ 8.78 billion in 2023 and is projected to hit the market valuation of US$ 22.71 billion by 2032 at a CAGR of 11.07% during the forecast period 2024–2032.
China pruritus therapeutics market was valued at US$ 1,025.8 million in 2023 and is estimated to surpass the market size of US$ 1,711.1 million by 2032 at a CAGR of 5.58% during the forecast period 2024–2032.
South Korea pruritus therapeutics market was valued at US$ 288.01 million in 2023 and is estimated to surpass the market size of US$ 428.01 million by 2032 at a CAGR of 4.50% during the forecast period 2024–2032.
Taiwan pruritus therapeutics market was valued at US$ 174.67 million in 2023 and is estimated to surpass the market size of US$ 225.53 million by 2032 at a CAGR of 2.88% during the forecast period 2024–2032.
Scaffold technology market was valued at US$ 1,395.15 million in 2024 and is projected to surpass the market size of US$ 5,570.75 million by 2033 at a CAGR of 16.63% during the forecast period 2025–2033.
Japan pruritus therapeutics market was valued at US$ 582.2 million in 2023 and is estimated to surpass the market size of US$ 1,011.5 million by 2032 at a CAGR of 6.33% during the forecast period 2024–2032.
Asia Pacific Preventive Vaccines Market was valued at US$ 20.9 billion in 2023 and is projected to surpass the market valuation of US$ 63.11 billion by 2032 at a CAGR of 13.07% during the forecast period 2024–2032.
Global Regenerative Medicine Market was valued at US$ 59.68 billion in 2023 and is projected to reach a valuation of US$ 472.95 billion by 2032 at a CAGR of 25.86% during the forecast period 2024–2032.